Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Conditions
Advanced Non-squamous Non-small-cell Lung Cancer · Advanced Squamous Non-Small Cell Lung Carcinoma · Metastatic Non-squamous Non Small Cell Lung Cancer · Metastatic Squamous Non-Small Cell Lung Carcinoma · Non-small Cell Lung Cancer · Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Pioneer Research Center, LLC, Bullhead City, Arizona, United States
Contact: Principal Investigator (Hamdy Mohtaseb, MD)Clermont Oncology Center, Clermont, Florida, United States
Contact: Principal Investigator (Gopal Kunta, MD)Oncology & Hematology Associates of West Broward, Coral Springs, Florida, United States
Contact: Principal Investigator (Sumit Sawhney, MD)Helios Clinical Research, Fort Lauderdale, Florida, United States
Contact: Study coordinator (Kylee Charlemagne) · kylee.charlemagne@heliosclinical.com · 645-225-9003Contact: Principal Investigator (Edgardo Santos, MD)Bioresearch Partner, Hialeah, Florida, United States
Contact: Principal Investigator (Luis Rangel, MD)University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Richa Dawar, MD)Bioresearch Partner, Miami, Florida, United States
Contact: Principal Investigator (Javier Perez Fernandez, MD)Mid Florida Hematology and Oncology Center, Orange City, Florida, United States
Contact: Principal Investigator (Santosh Nair, MD)BRCR Medical Center, Inc., Plantation, Florida, United States
Contact: Principal Investigator (Harshad Amin, MD)Michigan Hematology and Oncology Consultants, Dearborn, Michigan, United States
Contact: Principal Investigator (Faisel Musa, MD)Oakland Medical Group, Farmington Hills, Michigan, United States
Contact: Study coordinator (Catherine Maples) · Catherine.Maples@profoundresearch.com · 517-375-3057Contact: Principal Investigator (Jeffrey Margolis, MD)Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States
Contact: Principal Investigator (Erev Tubb, MD)Gabrail Cancer and Research Center, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail, MD)Texas Oncology - Austin Central, Austin, Texas, United States
Contact: Principal Investigator (James Uyeki, MD)World Research Link, Baytown, Texas, United States
Contact: Study coordinator (Isabel Navarrete) · isabel.navarrete@worldresearchlink.com · 833-832-8328Contact: Principal Investigator (Amir Rasheed, MD)